Home - NeuRA Foundation

When you need to say goodbye, twice.

When you love someone with dementia, you lose them - and say goodbye - twice. This is Margie's story.

'You're invited into my home'

At 34, Amanda learnt she carried a gene that would result in young onset Alzheimer's. Fourteen years later, she is feeling the early symptoms of the disease. Today, she invites you into her home to understand what that's like and how an Alzheimer's clinical trial is giving her incredible hope.

The cold case of schizophrenia – broken wide open!

It is early days, but can you imagine the treatment implications if we’ve identified a new biological basis for the disease?

Are you a Discovery Partner?

Will you become a Discovery Partner, invest in all our futures, and help painful and tormenting diseases and disorders become a thing of the past?

Leaving a bequest to NeuRA

Leaving a gift to NeuRA will help us find the cures so urgently needed. It won’t cost you anything now, but it is one of the most powerful ways to support our work into the future.

Restoring function and building confidence

The Canakinumab Add on Treatment for Schizophrenia (CATS) trial aims to establish whether a particular treatment, canakinumab, when taken alongside antipsychotic medication, has a positive effect on language, memory and other symptoms of schizophrenia.

We're not ready for this tsunami

The Rushton family weren't ready for Bob - husband, father, provider - to be struck down by dementia in his 40s. Our nation isn't ready either, with dementia soon to become Australia's biggest killer. We must act now.

Win a car and support NeuRA research!

NeuRA is a recipient of funds raised through the ASX Thomson Reuters Charity Foundation Art Union.